Jump to Navigation

Facebook Connect

User login

NLA Meetings

Meeting Info

The NLA Scientific Sessions will be packed with thought-provoking panel discussions, stimulating educational sessions, and expert speakers in the field of Clinical Lipidology focusing on recent cholesterol guidelines and recommendations, and how you can apply them to your practice. In addition, you cal also look forward to the following:

At the Scientific Sessions, you can also network with colleagues and world-renowned faculty in lipidology, share innovative ideas, and take advantage of the opportunity to earn continuing education credits, all while enjoying the city of Chicago.

The Scientific Sessions will allow you to connect, collaborate, and educate yourself and others about Clinical Lipidology and related issues.

Click here to download the program.

This information is still being developed by our faculty and will be posted here when available.

Upon completion of the educational activity, participants should be able to:

Target Audience
This activity is designed to meet the needs of physicians, physician assistants, pharmacists, registered nurses, nurse practitioners, advance practice registered nurses and registered dietitians with an interest in lipid management.

Type of Activity
Live Activity
Knowledge (Sessions I- X, XII Pediatric Dyslipidemia, XII Everyday Patient Cases)
Application (Sessions XI, Session XII Women's Issues)

CME credit provided by the National Lipid Association
Physicians
The National Lipid Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The National Lipid Association designates this live activity for a maximum of 19.50 AMA PRA Category 1 Credits™. Physicians should claim only credit commensurate with the extent of their participation in this activity.

Physician Assistants
NCCPA accepts AMA PRA Category 1 Credits™ from organizations accredited by the ACCME.

Dietitians
The National Lipid Association is a Continuing Professional Education (CPE) Accredited Provider with the Commission on Dietetic Registration (CDR). Registered dietitians (RDs) and dietetic technicians, registered (DTRs) will receive 19 continuing professional education units (CPEUs) for completion of this program/ materials. CDR Accredited Provider #NL002.

American Academy of Family Physicians
This Live activity, 2015 National Lipid Association Annual Scientific Sessions, with a beginning date of 06/11/2015, has been reviewed and is acceptable for up to 19.00 Elective credit(s) by the American Academy of Family Physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

CE credit provided by Postgraduate Institute for Medicine

Pharmacists

Postgraduate Institute for Medicine is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Session I- Universal Activity Number 0809-9999-15-012-L01-P (Knowledge)
Postgraduate Institute for Medicine designates this continuing education activity for 2.0 contact hour(s) (.20 CEUs) of the Accreditation Council for Pharmacy Education

Session II- Universal Activity Number 0809-9999-15-013-L01-P (Knowledge)
Postgraduate Institute for Medicine designates this continuing education activity for 1.5 contact hour(s) (.15 CEUs) of the Accreditation Council for Pharmacy Education

Session III – Universal Activity Number 0809-9999-15-014-L01-P (Knowledge)
Postgraduate Institute for Medicine designates this continuing education activity for 2.0 contact hour(s) (.20 CEUs) of the Accreditation Council for Pharmacy Education

Session IV– Universal Activity Number 0809-9999-15-015-L01-P (Knowledge)
Postgraduate Institute for Medicine designates this continuing education activity for 1.5 contact hour(s) (.15 CEUs) of the Accreditation Council for Pharmacy Education

Session V – Universal Activity Number 0809-9999-15-016-L01-P (Knowledge)
Postgraduate Institute for Medicine designates this continuing education activity for 2.0 contact hour(s) (.20 CEUs) of the Accreditation Council for Pharmacy Education

Session VI – Universal Activity Number 0809-9999-15-017-L01-P (Knowledge)
Postgraduate Institute for Medicine designates this continuing education activity for 1.25 contact hour(s) (.125 CEUs) of the Accreditation Council for Pharmacy Education

Session VII – Universal Activity Number 0809-9999-15-018-L01-P (Knowledge)
Postgraduate Institute for Medicine designates this continuing education activity for 1.25 contact hour(s) (.125 CEUs) of the Accreditation Council for Pharmacy Education

Session VIII – Universal Activity Number 0809-9999-15-019-L01-P (Knowledge)
Postgraduate Institute for Medicine designates this continuing education activity for 1.0 contact hour(s) (.10 CEUs) of the Accreditation Council for Pharmacy Education

Session IX – Universal Activity Number 0809-9999-15-020-L01-P (Knowledge)
Postgraduate Institute for Medicine designates this continuing education activity for 1.0 contact hour(s) (.10 CEUs) of the Accreditation Council for Pharmacy Education

Session X – Universal Activity Number 0809-9999-15-021-L01-P (Knowledge)
Postgraduate Institute for Medicine designates this continuing education activity for 1.0 contact hour(s) (.10 CEUs) of the Accreditation Council for Pharmacy Education

Session XI – Universal Activity Number 0809-9999-15-022-L01-P (Application)
Postgraduate Institute for Medicine designates this continuing education activity for 1.75 contact hour(s) (.175 CEUs) of the Accreditation Council for Pharmacy Education

Session XII Pediatric Dyslipidemia – Universal Activity Number 0809-9999-15-024-L01-P (Knowledge)
Postgraduate Institute for Medicine designates this continuing education activity for 3.0 contact hour(s) (.30 CEUs) of the Accreditation Council for Pharmacy Education

Session XII Women’s Issues – Universal Activity Number 0809-9999-15-025-L01-P (Application)
Postgraduate Institute for Medicine designates this continuing education activity for 3.0 contact hour(s) (.30 CEUs) of the Accreditation Council for Pharmacy Education

Session XII Everyday Patient Cases – Universal Activity Number 0809-9999-15-023-L01-P (Knowledge)
Postgraduate Institute for Medicine designates this continuing education activity for 3.0 contact hour(s) (.30 CEUs) of the Accreditation Council for Pharmacy Education

Nursing
This educational activity for 19 contact hours is provided by the Postgraduate Institute for Medicine.
Postgraduate Institute for Medicine is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
Session I- 2.0 credits; Session II- 1.5 credits; Session III- 2.0 credits; Session IV- 1.5 credits; Session V- 2.0 credits; Session VI- 1.1 credits; Session VII- 1.1 credits; Session VIII- 1.0 credits; Session IX- 1.0 credits; Session X- 1.0 credits; Session XI- 1.7 credits; Session XII: Pediatric Dyslipidemia- 3.0 credits; Session XII: Women’s Issues- 3.0 credits; Session XII: Everyday Patient Cases- 3.0 credits.  

Pharmacotherapy contact hours for Advance Practice Registered Nurses to be determined.

Educational Objectives
At the conclusion of this activity, registered nurses and nurse practitioners should be able to provide appropriate counsel for patients and their families.

At the conclusion of this activity, all participants should be able to:

Session I- NLA Expert Panel Recommendations

  • Define the National Lipid Association’s Recommendations for Patient-Centered Management of Dyslipidemia
  • Describe the NLA recommendations for management of dyslipidemias in special populations

Keynote Session- Clinical Implications of Novel Targets and Emerging Therapies

  • Describe the efficacy, safety, and mechanisms of action of novel lipid-targeted pharmacotherapies
  • Critically appraise current clinical trial results in order to apply evidence-based medicine into daily clinical practice
  • Assess the implications of ongoing lipid treatment outcomes  trials for the future clinical management of patients with dyslipidemia

Session III- Controversies in Statin Safety

  • Review the impact of statin therapy on glycemic control in diabetes and the risk of new onset diabetes in the statin treated patient
  • Review the risk and the  mechanisms  for  statin induced myopathy
  • Describe the evidence for the risk of cognitive impairment with statin treatment

Session IV- Lifestyle Management to Reduce Cardiovascular Risk 

  • Review the lifestyle recommendations in the 2013 ACC/AHA guidelines
  • Identify the  nutrient intake and food choices to meet these  guidelines

Session V- Treatment Strategies in Obesity Management

  • Describe the current guidelines on the diagnosis, management and treatment of obesity
  • Review the approved pharmacologic therapies for the treatment of obesity including their impacts on lipid metabolism
  • Identify the pros and cons of bariatric surgery for the treatment of obesity

Session VI- Special Symposium: Controversies in Assessing CVD Risk

  • Describe  the effectiveness of available risk assessment tools in predicting 10 year and lifetime CV risk
  • Compare and contrast the risk predictor tools in diverse patient populations

Session VII- Consensus and Controversies in Clinical Lipid Management

  • Evaluate the evidence-based approach to the 2013 ACC/AHA guidelines for the management of blood cholesterol in adults.
  • Compare and contrast the effectiveness of utilizing other scientific evidence in   the management decisions of dyslipidemia

Session VIII- Understanding Hypertension Management Guidelines

  • Evaluate the clinical implications of the 2013 Hypertension guidelines
  • Discuss the controversies and impact of the new hypertension guidelines on clinical management in special patient populations

Session IX- Comprehensive Management of Diabetes

  • Discuss the controversies in managing  type 2 diabetes mellitus using guideline recommendations and evidence-based treatment
  • Compare therapeutic options for the treatment of dyslipidemia in patients  with diabetes

Session X- Case Discussions: Treatment Strategies for High Risk Populations

  • Describe combination therapies for the management of complex lipid disorders and residual risk
  • Identify the potential roles that novel lipid therapies may play in reducing residual risk in patients with CVD
  • Discuss the management of dyslipidemia in special populations based on gender, culture, and ethnicity

Session XI- Adherence Challenges and Strategies for the Practicing Clinician

  • Review the scientific research relating to adherence to lipid-lowering therapies and the  impact on  treatment decisions
  • Implement strategies that  improve patient adherence and compliance  to lipid-modifying therapies
  • Outline the impact of various diets on short-term and long-term weight loss

Session XII- Pediatric Dyslipidemia – Guidelines and Pharmacology Workshop

  • Appraise treatment recommendations and evidence for screening, diagnosing and treating dyslipidemias in pediatric patients
  • Illustrate the importance of universal screening during childhood and cascade lipid screening of family members of known familial hypercholesterolemia (FH) patients

Session XII- Women’s Issues Workshop

  • Appraise the evidence for screening, diagnosing and treating FH in women of childbearing potential and during pregnancy
  • Explain the  CVD effects of menopausal hormone therapy (MHT)
  • Implement appropriate dyslipidemia management during menopause transition

Session XII- Everyday Patient Cases- What to do After the Evidence Workshop

  • Describe the identification and treatment  of residual risk in young patients with cardiovascular disease (CVD)
  • Discuss the appropriate lipid management strategies for patients with chronic kidney disease
  • Discuss the underlying CVD risk in patients with HIV

 

Criteria for Success:
Statements of credit will be awarded based on the participant´s attendance and submission of the activity evaluation form. A statement of credit will be available upon completion of an online evaluation/claimed credit form at www.lipid.org/cme.
For Pharmacists: Upon successfully completing the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 4 weeks.

Disclosure Statement:
It is the policy of NLA to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. The faculty must disclose to the participants any significant relationships with commercial interests whose products or devices may be mentioned in the activity or with the commercial supporter of this continuing education activity. Identified conflict of interest is resolved by NLA prior to accreditation of the activity. NLA planners and reviewers have no relevant financial relationships to disclose.

Commercial Support:
Full notification of commercial support will be provided in the activity syllabus.

Terry A. Jacobson, MD, FNLA

President, National Lipid Association
Director, Office of Health Promotion and Disease Prevention
Professor of Medicine
Emory University
Atlanta, GA
Diplomate, American Board of Clinical Lipidology

Kaye-Eileen Willard, MD, FNLA

President, Midwest Lipid Association
Chief of Department of Medicine
Medical Director, Chronic Disease Management
Wheaton Franciscan Healthcare, All Saints
Racine, WI
Diplomate, American Board of Clinical Lipidology

Carl E. Orringer, MD, FACC, FNLA

President-Elect, National Lipid Association
Associate Professor of Medicine
University of Miami
School of Medicine
Miami, FL
Diplomate, American Board of Clinical Lipidology

Laxmana M. Godishala, MD, FNLA

Clinical Assistant Professor
University of Minnesota Medical School
Edina, MN
Diplomate, American Board of Clinical Lipidology

Anne C. Goldberg, MD, FNLA

Associate Professor of Medicine
Washington University School of Medicine
St. Louis, MO
Diplomate, American Board of Clinical Lipidology

Robert A. Wild, MD, MPH, PhD, FNLA

Professor, Clinical Lipidology and Obstetrics and Gynecology
Oklahoma University Health Sciences Center
Oklahoma City, OK
Diplomate, American Board of Clinical Lipidology

Philip Barter, MD, PhD

Professor, University of New South Wales, Australia
President, International Atherosclerosis Society
New South Wales, Australia

Harold E. Bays, MD, FNLA

Medical Director/President
Louisville Metabolic and Atherosclerotic
Research Center
Louisville, KY
Diplomate, American Board of Clinical Lipidology

Peter F. Belamarich, MD

Associate Professor of Clinical Pediatrics
Albert Einstein College of Medicine
Medical Director, Pediatric Ambulatory Subspecialty Services,
The Children’s Hospital at Montefiore
Bronx, NY

Irwin Benuck, MD, PhD

Division Head, Community-Based Pediatrics
Professor of Pediatrics
Northwestern University Feinberg School of Medicine
Chicago, IL

Vera A. Bittner, MD, MSPH, FNLA

Professor of Medicine
Section Head, Preventive Cardiology
University of Alabama at Birmingham
Birmingham, AL
Diplomate, American Board of Clinical Lipidology

Piers R. Blackett, MD, FNLA

Professor
University of Oklahoma Health Sciences Center
Oklahoma City, OK
Diplomate, American Board of Clinical Lipidology

Lynne T. Braun, PhD, CNP, FNLA

Professor of Nursing and Nurse Practitioner
Rush University Medical Center
Chicago, IL

Sonja L. Connor, MS, RD, FNLA

Associate Professor of Research
Department of Medicine
Oregon Health Sciences University
Portland, OR

Stephen R. Daniels, MD, PhD, FNLA

Chairman, Department of Pediatrics
University of Colorado School of Medicine
Pediatrician-in-Chief
L. Joseph Butterfield Chair in Pediatrics
Children's Hospital Colorado
Aurora, CO

Sarah D. De Ferranti, MD, MPH

Director, Preventive Cardiology Program
Assistant Professor of Pediatrics,
Harvard Medical School
Boston, MA

Daniel A. Duprez, MD, PhD, FNLA

Professor, Department of Medicine, Cardiovascular Division,
University of Minnesota
Donald and Patricia Garofalo Chair for Preventive Cardiology
Director of Research, Rasmussen Center for Cardiovascular Disease Prevention
Associate Director, Cardiovascular Clinical Trials Center
Minneapolis, MN

J. Christopher Eagon, MD

Associate Professor, Surgery
Division of General Surgery
Section of Minimally Invasive Surgery

Washington University School of Medicine
St. Louis, MO

Robert H. Eckel, MD, FNLA

Charles A. Boettcher Endowed Chair in Atherosclerosis
Professor of Medicine - Division of Endocrinology, Metabolism and Diabetes, and Cardiology
Professor of Physiology and Biophysics
Program Director, Adult General Clinical Research Center
Aurora, CO
Diplomate, American Board of Clinical Lipidology

Keith C. Ferdinand, MD, FNLA

Professor of Clinical Medicine
Tulane University Heart and Vascular Institute
New Orleans, LA

W. Timothy Garvey, MD

Professor and Chair
Department of Nutrition Sciences
School of Health Professions
Senior Scientist
Nutrition Obesity Research Center
Birmingham, AL

Kenneth A. Jamerson, MD

Professor, Internal Medicine
Frederick G.L. Huetwell Collegiate Professor of Cardiovascular Medicine
University of Michigan Medical School
Ann Arbor, MI 

Peter H. Jones, MD, FNLA

Associate Professor
Department of Medicine Center for Cardiovascular
 Disease Prevention
Baylor College of Medicine
Houston, TX
Diplomate, American Board of Clinical Lipidology

Rae-Ellen W. Kavey, MD

Pediatric Cardiologist
Rochester, NY

Penny Kris-Etherton, PhD, RD, FNLA

Distinguished Professor of Nutrition
The Pennsylvania State University
University Park, PA

Edgar V. Lerma, MD, FNLA

Clinical Professor of Medicine
University of Illinois at Chicago
Chicago, IL

Donald M. Lloyd-Jones, MD, ScM

Senior Associate Dean
Director, Northwestern University Clinical and Translational Sciences (NUCATS)
Institute Chair and Professor of Preventive Medicine
Northwestern University Feinberg School of Medicine
Chicago, IL

Kevin C. Maki, PhD, FNLA

Chief Science Officer
Midwest Center for Metabolic & Cardiovascular Research
Chicago, IL

Patrick E. McBride, MD, MPH

Professor of Medicine and Family Medicine,
Co-Director Preventive Cardiology,
Associate Dean, University of Wisconsin
Madison, WI

Janet B. McGill, MD

Professor, Medicine
Division of Endocrinology, Metabolism and Lipid Research
St. Louis, MO

James M. McKenney, PharmD, FNLA

CEO, National Clinical Research, Inc.
Manakin Sabot, VA

Patrick M. Moriarty, MD, FNLA

Professor, Department of Internal Medicine
Director, Division of Clinical Pharmacology and
Atherosclerosis/ Lipid Apheresis Center
University of Kansas Medical Center
Kansas City, KS

Pamela B. Morris, MD, FNLA

Director, Preventive Cardiology
Co-Director, Women’s Heart Care
Medical University of South Carolina
Charleston, SC

Kenneth Resnicow, PhD

Professor
Health Behavior & Health Education
School of Public Health
University of Michigan
Ann Arbor, MI

Paul M. Ridker, MD

Senior Physician, Brigham and Women's Hospital
Eugene Braunwald Professor of Medicine,
Harvard Medical School
Boston, MA

Robert S. Rosenson, MD

Director
Cardiometabolic Disorders
Mount Sinai Heart
Professor of Medicine (Cardiology)
Icahn School of Medicine
Mount Sinai
New York, NY
Diplomate, American Board of Clinical Lipidology

Joyce L. Ross, MSN, CRNP, FNLA

President, Northeast Lipid Association
Past-President, Preventive Cardiovascular Nurses Association
Consultative Education Specialist,
  Cardiovascular Risk Intervention
University of Pennsylvania Health System- Retired
Philadelphia, PA

Shoeb J. Sitafalwalla, MD

Medical Director
South Asian Cardiovascular Center
Division of Cardiovascular Disease
Advocate Lutheran General Hospital
Park Ridge, IL

Neil J. Stone, MD, FNLA

Bonow Professor of Medicine
Feinberg School of Medicine
Northwestern University
Suzanne and Milton Davidson Distinguished
Physician and Medical Director, Vascular Center
Bluhm Cardiovascular Institute
Northwestern Memorial Hospital
Chicago, IL
Diplomate, American Board of Clinical Lipidology

James A. Underberg, MD, MS, FNLA

Clinical Assistant Professor of Medicine
NYU School of Medicine & NYU Center for Prevention of Cardiovascular Disease
Director Bellevue Hospital Lipid Clinic
New York, NY
Diplomate, American Board of Clinical Lipidology

Elaine M. Urbina, MD

Director, Preventive Cardiology
Cincinnati Children's Hospital Medical Center
Cincinnati Children's Heart Institute, Division of Pediatric Cardiology
Cincinnati, OH

Don P. Wilson, MD, FNLA

Medical Director, Pediatric Cardiovascular Health
  and Risk Prevention Program
Cook Children’s Medical Center
Fort Worth, TX
Diplomate, American Board of Clinical Lipidology

Kathleen L. Wyne, MD, PhD, FNLA

Assistant Professor of Medicine
Weill Cornell Medical College
Houston, TX
Diplomate, American Board of Clinical Lipidology


Online Registration is now closed. We will be accepting onsite registrations.

You can still register online for all CME/CE Satellite Symposia
by clicking the "Symposia" tab to the left.

2015 EXHIBITS

Plan now for your company to participate in the National Lipid Association’s Annual Scientific Sessions in Chicago. Our meeting provides you with a unique opportunity to reach our target audience of Lipidologists, Cardiologists, Endocrinologists, Primary Care Physicians and Allied Health Professionals involved in dyslipidemia management, as well as our distinguished board and faculty.

Our numerous sponsorship opportunities allow you to connect with our members in a whole new way, providing you with maximum return on your investment. The exhibit hall provides a unique setting for you and your company’s representatives to interact daily with attendees as they study the latest advances in their professions.

We look forward to your participation and seeing you in 2015!

Download Exhibit Prospectus

 

 

NLA Exhibitor Show Kit

NLA- Annual Sessions Company Descriptions

Aegerion Pharmaceuticals, Inc.

Aegerion Pharmaceuticals is a biopharmaceutical company dedicated to the development and commercialization of innovative, life-altering therapies for patients with debilitating and often fatal rare diseases. The company is based in Cambridge, Massachusetts and has an established international presence.

www.aegerion.com

 

Accreditation Council for Clinical Lipidology (ACCL)

The ACCL establishes, certifies, and maintains the clinical competencies of qualified and experienced health care professionals specializing in Clinical Lipidology (non-physician and physician).  Two levels of certification offered: Clinical Lipid Specialist (CLS) and Basic Competency in Clinical Lipidology (BCCL).

www.lipidspecialist.org

 

Amarin Pharma Inc.

Amarin Pharma Inc. is a biopharmaceutical company focused on the commercialization and development of therapeutics to improve cardiovascular health. Amarin's first FDA approved product is available in the United States by prescription.

www.amarincorp.com

 

American Board of Clinical Lipidology (ABCL)

The ABCL assesses and validates the specialized knowledge and advanced training required to practice in the dynamic and complex field of Lipidology.  The only certification program of its kind available to licensed physicians in the United States or Canada.

www.lipidboard.org

 

American Heart Association

Our mission is to build healthier lives, free of cardiovascular diseases and stroke. That single purpose drives all we do. The need for our work is beyond question.

www.heart.org

 

Amgen Inc.

Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. A biotechnology pioneer since 1980, Amgen has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential.

www.amgen.com

 

AstraZeneca

AstraZeneca is focused on the discovery, development and commercialization of medicines for the treatment of cardiovascular, metabolic, respiratory, inflammation, autoimmune, oncology, and neuroscience diseases.

www.astrazeneca.com

 

Boston Heart Diagnostics

Boston Heart Diagnostics is enabling healthcare providers and patients to improve heart health and prevent disease with our integrated diagnostics, personalized reporting and lifestyle management solution.

www.bostonheartdiagnostics.com

 

CardioDx Inc.

CardioDx, a molecular diagnostics company specializing in cardiovascular genomics, is committed to developing clinically validated tests that empower clinicians to better tailor care to each individual patient.

www.cardiodx.com

 

Carlson Laboratories, Inc.

Carlson celebrates 50 years of providing you with natural-source E products, award-winning fish oils and the freshest, purest vitamins and nutritional supplements.

www.carlsonlabs.com

 

Cardiology Today

SLACK Incorporated invites you to visit our booth to pick up your free issue of CARDIOLOGY TODAY – News & Perspective for the Cardiovascular Specialist. Also see Cardiology Today’s Intervention – a practical information resource for interventional cardiologists. To receive important email updates, register at Healio.com/Cardiology.

 

diaDexus, Inc.

diaDexus, Inc., based in South San Francisco California, USA develops and commercializes proprietary cardiovascular diagnostic products addressing unmet needs in cardiovascular disease. The diaDexus PLAC® Test is a simple blood test that measures Lp-PLA2, a vascular-specific inflammatory marker critical in the formation of rupture-prone plaque. Visit www.plactest.com for more information.

www.diadexus.com

 

Dupont Nutrition & Health

DuPont Nutrition & Health combines in-depth knowledge of food and nutrition with current research and expert science to provide healthy ingredients to the food, beverage and dietary supplement industries.

www.dupont.com

 

Egg Nutrition Center

Egg Nutrition Center is a credible source of nutrition and health science information and the acknowledged leader in research and education related to eggs.

www.eggnutritioncenter.org

 

Eli Lilly and Company

Lilly is a global healthcare leader that unites caring with discovery to make life better for people around the world. We were founded in 1876 by a man committed to creating high-quality medicines that meet real needs, and today we remain true to that mission. To learn more, visit www.lilly.com.

 

Endurance Products Co.

Endurance Products Company (EPC), manufactures and markets Endur-acin®, the clinically proven wax-matrix extended release niacin since 1976.  RCTs of Endur-acin® have consistently demonstrated an unsurpassed in tolerability with dropout rates averaging 4.5%. Clinical samples of are available.

www.endur.com

 

Genzyme

Genzyme discovers and delivers transformative therapies for patients with rare and special unmet medical needs, providing hope where there was none before. Visit www.genzyme.com.

 

Health Diagnostic Laboratory, Inc.

Health Diagnostic Laboratory, Inc.’s comprehensive testing services aid clinicians in earlier, more precise disease detection and targeted disease management, resulting in improved patient outcomes.

www.hdlabinc.com

 

Kaneka Pharma America, LLC

Kaneka’s Liposorber Apheresis System is FDA approved for the acute reduction of LDL cholesterol (70-80%) in patients with Familial Hypercholesterolemia and patients who cannot meet their LDL-C goals despite maximum drug therapy. The Liposorber treatment is reimbursed by government and private insurance, and is used in hospitals, clinics, and physician offices across the country.

www.liposorber.com

 

Kowa Pharmaceuticals America, Inc.

Kowa Pharmaceuticals America, Inc. is focused in the area of cardiometabolic diseases and focuses its efforts on the successful commercialization of its current and near-term portfolio of pharmaceutical products, and business development activities. For more information about Kowa Pharmaceuticals America, visit www.kowapharma.com.

 

Lipoprotein(a) Foundation

The mission of the Lipoprotein(a) Foundation is to prevent cardiovascular events due to high Lipoprotein(a) by revealing this inherited lipid risk for early cardiovascular disease, empower patients and save lives.  We are a patient-founded, 501(c)(3) non-profit organization.

www.lipoproteinafoundation.org

 

Merck

Today's Merck is a global healthcare leader working to help the world be well. 

www.merck.com

 

The National Lipid Association

The NLA is a nonprofit, multidisciplinary medical society focused on enhancing the practice of lipid management in clinical medicine, offering unmatched educational and networking opportunities.

www.lipid.org

 

Rare Disease Report

Rare Disease Report’s website, newsletter, and monthly print publication increases awareness of rare diseases by developing and disseminating relevant information to physicians and the orphan disease community.

www.raredr.com

 

Quest Diagnostics

Quest Diagnostics, the world’s leading provider of diagnostic testing, information and services, offers the Cardio IQ Solution—a comprehensive approach to heart health.  Visit 4myheart.com and QuestDiagnostics.com

 

ReachMD

ReachMD is an award-winning medical broadcasting company delivering education and information to healthcare professionals nationwide through an on air, online, and mobile distribution network.

www.reachmd.com

 

Sanofi and Regeneron

Sanofi, a global healthcare leader, discovers, develops, and distributes therapeutic solutions focused on patients’ needs. Regeneron, a leading biopharmaceutical company, discovers, develops, manufactures, and commercializes biologic medicines for serious medical conditions. Since 2007, Sanofi and Regeneron have collaborated to develop and commercialize fully human monoclonal antibodies utilizing proprietary technologies.

www.regeneron.com

 

Synageva

Synageva is a biopharmaceutical company focused on the discovery, development, and commercialization of products for patients with rare diseases. Our pipeline programs include the lead program, Kanuma™ (sebelipase alfa) for lysosomal acid lipase deficiency (LAL D), SBC-103 for mucopolysaccharidosis IIIB (MPS IIIB), and SBC-105 for generalized arterial calcification of infancy (GACI) and other rare calcification diseases.

www.synageva.com

 

Lipidpalooza

Fundraising at the House of Blues

Saturday, June 13 | 7:30–10:30 PM

$195 per person

Join us at the House of Blues in downtown Chicago for an evening packed with music, food, and fun. Bring your family and support the Foundation of the National Lipid Association (FNLA), while enjoying today’s most popular songs, delicious food, and tasty drinks with colleagues and friends. FNLA board member and Chicago native Dr. Alan Brown and his band, This End Up, will provide the tunes for the evening! Take advantage of the complimentary photo booth to capture the unforgettable occasion and take home memories.

 

Meet in the Palmer House Hotel lobby at 7:00 pm for a walk to the House of Blues.


Honors & Awards Ceremony

Saturday, June 13 | 6:30–7:30 pm

 
The National Lipid Association, in cooperation with the certification bodies of the American Board of Clinical Lipidology (ABCL) and the Accreditation Council for Clinical Lipidology (ACCL) will host its annual Honors and Awards Ceremony. The ABCL and ACCL will recognize the achievements of those who successfully passed the ABCL or Clinical Lipid Specialist (CLS) exams. The NLA will also present the Distinguished Achievement Award, the Honorary Lifetime Member Award, and the President’s Service Award, as well as induct the 2015 class of Fellows of the NLA. Join us for this special event to honor your colleagues, and enjoy a cocktail and some hors d’oeuvres.
 
 

Non-CME Workshop/Symposium

Workshop: Navigating the NLA Annual Summary of Clinical Lipidology 2015: Present and Future

Friday, June 12
6:30 - 7:45 AM

Host:
Harold Bays, MD, FTOS, FACC, FACE, FNLA
Medical Director/President
L-MARC Research Center
Louisville, KY
Diplomate, American Board of Clinical Lipidology

The recently published NLA Annual Summary of Clinical Lipidology 2015 is an essential resource for the busy lipidologist. Its futuristic format presentation of "all-things-lipids" provides "one-stop-shopping" for the very latest in the comprehensive basics of Clinical Lipidology, and is applicable to both basic scientists and beginning clinicians alike. In this symposium, Dr. Harold Bays will provide insights to its genesis, its unique navigation format, exciting plans for future novel enhancements, as well as provide an opportunity for attendees to provide feedback and input to the upcoming 2016 edition.


Workshop: Publishing in the Journal of Clinical Lipidology

Sunday, June 14
7:00–7:55 AM

Host:
W. Virgil Brown, MD, FNLA
Charles Howard Candler Professor Emeritus
Emory University School of Medicine
Atlanta, GA
Diplomate, American Board of Clinical Lipidology

During the NLA Scientific Sessions, Dr. Virgil Brown, along with a representative from Elsevier, will be on hand for a non-CME workshop on tips for getting published in the Journal. To find out more about this session and to register, visit lipid.org/sessions. There is no additional cost to register for this non-CME Symposium; simply let us know your interest in participating on the registration form.

Palmer House Hotel

For reservations, please call 1-877-865-5321 or 1-312-726-7500 and ask for the National Lipid Association's room rate. A special room rate starting at $229 per night plus tax has been arranged. This group rate will be available until May 19, 2015, or until the room block is fi­lled. Please make your reservation early as we do anticipate the room block will sell out.

To learn more about the hotel, please visit palmerhousehiltonhotel.com

 

 

 

Airline Discount

Book Your Airfare on Delta or United and receive up to 5% of your flight to Chicago.

 

Booking on Delta?

Go to delta.com and enter NML3K in the “Offer Code” box when searching for your flight.

 

Booking on United?

Go to united.com and enter ZUHQ793333 in the “Offer Code” box when searching for your flight.

 

Coming Soon...

0
No votes yet

June 11, 2015

7:00 – 9:00pm

CME/CE Dinner Symposium: Effective Management of Homozygous Familial Hypercholesterolemia: Therapeutic Strategies for a Complex Dyslipidemia 

In this activity, leading experts will discuss approaches to effectively identify patients with HoFH and the safety/efficacy profiles and appropriate utilization of currently available therapies, as well as emerging therapeutic approaches. 

To register for this satellite symposium, please visit www.vindicoCME.com/061115

Program Chair

James A. Underberg, MD, MS, FACPM, FACP, FASH, FNLA
Lipidology & Cardiovascular Disease Prevention
Clinical Assistant Professor of Medicine
NYU Medical School & NYU Center for CV Prevention
Director, Bellevue Hospital Lipid Clinic
Past President, Northeast Chapter National Lipid Association
New York, New York

 

Faculty

Seth J. Baum, MD, FACC, FACPM, FAHA, FNLA

Preventive and Integrative Cardiology

Medical Director, Women’s Preventive Cardiology

Christine E. Lynn Women’s Health & Wellness Institute

Boca Raton Regional Hospital

CMO, MB Clinical Research

President Elect of the ASPC

Boca Raton, Florida

 

Sergio Fazio, MD, PhD

The William and Sonja Connor Chair of Preventive Cardiology

Professor of Medicine, Physiology and Pharmacology

Director, Center for Preventive Cardiology

Knight Cardiovascular Institute

Oregon Health and Science University

Portland, Oregon

 

This activity is supported by an educational grant from Aegerion Pharmaceuticals, Inc.

This activity is facilitated by Vindico Medical Education.


 

June 12, 2015

6:30 - 7:45 AM

CME/CE Breakfast Symposium: Beyond Statin Therapy: A Comprehensive Approach to Dyslipidemia Management

This activity is designed to educate lipidologists, cardiologists, endocrinologists, & other HCPs involved in the management of patients with dyslipidemia & incorporates 3D technology & audience response system.

To register for this satellite symposium, please visit www.mlg-nla.com

Program Chair

Henry Ginsberg, MD

Irving Professor of Medicine

Director, Irving Institute for Clinical and Translational Research

Columbia University

New York, New York

 

Faculty

Stephen D. Wiviott, MD
Cardiovascular Division
Brigham and Women's Hospital
Associate Professor of Medicine
Harvard Medical School
Senior Investigator, TIMI Study Group
Boston, MA

Supported by an educational grant from Amgen Inc., and Lilly USA, LLC.

This activity is facilitated by Med Learning Group

 


 

 June 12, 2015

7:00 – 9:15pm

CME/CE Dinner Symposium: Lipid Management Beyond Statins: Biologic Basis, New Clinical Evidence, and Strategies

This 2.25-hour, highly interactive, CME-certified symposium will feature a faculty of 3 leading international experts who will address the complex interrelationships of cardiovascular disease risk and hypertriglyceridemia for an audience of approximately 175 clinicians, including internists, endocrinologists, and lipidologists. This audience is responsible for the diagnosis and management of lipid disorders and cardiometabolic risk.

To register for this satellite symposium, please visit http://events.medtelligence.net/nla2015.html

Program Chair

Peter Libby, MD

Cardiovascular Medicine

Brigham and Women’s Hospital

Mallinckrodt Professor of Medicine

Harvard Medical School

Boston, MA

 

Faculty

Michael Miller, MD

Professor of Cardiovascular Medicine, Epidemiology & Public Health

University of Maryland School of Medicine

Director, Center for Preventive Cardiology

University of Maryland Medical Center

Baltimore, MD

 

Harold E. Bays, MD

Medical Director / President

L-MARC Research Center

Louisville, KY

 

Supported by an educational grant from Amarin Pharma Inc.

This activity is facilitated by Medtelligence 


 

June 13, 2015

6:30 – 7:35am 

CME/CE Breakfast Symposium: Advancing Treatment for Lysosomal Acid Lipase Deficiency (LALD)

This 1-hour, engaging CME format is designed to foster learning via case-based discussions with expert panelists on the clinical presentation of LAL deficiency as well as current and emerging treatment options for patients diagnosed with this serious and often unrecognized disorder. The Town Hall will provide each attendee with an interactive forum, enabling participants to drive the discussion on the basis of their own clinical challenges. This initiative will be targeted to cardiologists, primary care and internal medicine physicians (PCPs), endocrinologists, and other physicians involved in the diagnosis and care of patients who may be affected by LAL deficiency.

To register for this satellite symposium, please visit http://www.medscape.org/sites/townhall/public/lysosomal-acid-lipase-defi...

Program Chair

James A. Underberg, MD, MS, FACPM, FACP, FASH, FNLA

Lipidology & Cardiovascular Disease Prevention

Clinical Assistant Professor of Medicine

NYU Medical School & NYU Center for CV Prevention

Director, Bellevue Hospital Lipid Clinic

Past President, Northeast Chapter National Lipid Association

New York, New York

 

Faculty

Don P. Wilson, MD, FNLA

Diplomate, American Board of Clinical Lipidology

Endowed Chair, Cardiovascular Health and Risk Prevention

Pediatric Endocrinology and Diabetes

Cook Children’s Medical Center

Fort Worth, Texas

 

Patrick Moriarty, MD

Professor of Medicine

Director of Clinical Pharmacology/Atherosclerosis & Lipoprotein Apheresis Center

University of Kansas Medical Center

Kansas City, Kansas

 

Supported by an educational grant from Synageva 

This activity is facilitated by Medscape 

 


 

June 13, 2015

6:30 – 7:45am

CME/CE Breakfast Symposium: Insights Into Vascular and Antioxidant Effects of EPA Relevant to Atherogenesis

This 1-hour, highly interactive, CME-certified symposium will feature a faculty of 2 leading international experts who will address the complex interrelationships involved in atherosclerosis development, including the role played by hypertriglyceridemia, the biology of oxidation, and endothelial and inflammatory actions, for an audience of approximately 125 clinicians, including internists, endocrinologists, and lipidologists. This audience is responsible for the diagnosis and management of lipid disorders and cardiometabolic risk.

To register for this satellite symposium, please visit http://events.medtelligence.net/nla61315.html

Program Chair

Sergio Fazio, MD, PhD

William and Sonja Connor Chair of Preventive Cardiology

Professor of Medicine, Physiology & Pharmacology

Director, Center for Preventive Cardiology

Knight Cardiovascular Institute

Oregon Health and Science University

Portland, OR

 

Faculty

R. Preston Mason, PhD

Director, Lipid Biophysics Lab

Lecturer on Medicine

Cardiovascular Division

Brigham & Women’s Hospital

Harvard Medical School

Boston, MA

 

Supported by an educational grant from Amarin Pharma Inc.

This activity is facilitated by Medtelligence 

 

 

 

 

 

 

2015 SATELLITE SYMPOSIA GUIDELINES

The National Lipid Association (NLA) has established that independently developed and CME/CE certified satellite symposia held in conjunction with the scientific meetings of the NLA are valuable opportunities to provide continuing education for our members. In this regard, we are pleased to offer satellite symposia slots in conjunction with our 2015 Clinical Lipid Updates.

Satellite symposia address educational needs and performance gaps that complement the NLA scientific program agenda. They may include one or a number of speakers and may cover one or several topics addressing the educational gaps of lipid specialists.

The following deadlines and guidelines provide important information about holding a Satellite Symposium at the 2015 Clinical Lipid Updates and the process for completing a symposium proposal. Please contact the NLA business development department directly (contact below) should there be any questions or further information required. See you in 2015!

DOWNLOAD 2015 SATELLITE SYMPOSIA GUIDELINES 2015

Contact:
Amina Resheidat
Program Coordinator
904-309-6212

aresheidat@lipid.org

0
No votes yet

This form is for submitting questions you may expect to have for presenters on the various topics offered through out the NLA's 2015 Annual Scientific Session. Please provide your name, select the talk for which your questions applies and provide a brief synopsis of your question. For reasons of time, we cannot guarantee that every speaker will be able to answer every question submitted.



by Dr. Radut.